retatrutide alternative – new weight loss medication in development Retatrutide: A Promising Option for

Esposito, Feasibility of simplification from a basal-bolus insulin regimen to a fixed-ratio formulation of basal insulin plus a GLP-1RA or to basal insulin plus an SGLT2 inhibitor: BEYOND, a randomized, pragmatic trial

Foundayo is the second oral GLP-1 analog approved for weight loss, following Wegovy tablets, which were approved in January

NielsenIQ, Homescan GLP-1 Panel Survey (Aug/Sep 2024) MSA through integration of NCP and EMR data as of September 2024 NielsenIQ, Homescan GLP-1 Panel Survey

Doctors warn against the serious long-term health problems caused by a regular loss of muscle mass in patients who have adopted a yoyo regime of weight loss and regain

Hotels can often provide in-room refrigeration, but it is worth verifying before arrival

Track the whole GLP-1 field I keep a running tracker of every GLP-1 and incretin drug, approved and still in the pipeline, with what each one targets, how far along it is, and what's coming next